Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19
Clinical trial NCT04824391 · COMPLETED
Trial details
- NCT number
- NCT04824391
- Sponsor
- Health Institutes of Turkey
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-10
- Primary completion
- 2022-03-11
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.